National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 6) (PB 70 of 2018) (Cth)

PB 70 of 2018

National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 6)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        27  July 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 6).

(2)   This Determination may also be cited as PB 70 of 2018.

1. Commencement

This Determination commences on 1 August 2018.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Follitropin Beta

Insert

Follitropin delta

[2]     Schedule 1, after item dealing with Glatiramer

Insert

Glecaprevir with pibrentasvir

[3]     Schedule 1, after item dealing with Natalizumab

Omit

Nebivolol

[4]     Schedule 2, after item dealing with Naproxen

Insert

Nebivolol